AQST vs MCD · rev $28.3M vs P/E 23, rev $25.92B
Aquestive Therapeutics Inc (AQST) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
AQST currently screens at market cap $493.0M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the AQST and MCD stock pages for the full models.
Not investment advice.